Prospective study on the relationship between melanoma deletion factor 2 and acute myocardial infarction

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100043033

Enrollment

Unknown

Registered

2021-02-04

Start date

2021-03-01

Completion date

Unknown

Last updated

2021-07-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute myocardial infarction

Interventions

AIM:N/A

UAP:N/A

SAP:N/A

Control group :N/A

Eligibility

Sex/Gender

All

Age

18 Years to 85 Years

Inclusion criteria

Inclusion criteria: Patients who are diagnosed with coronary heart disease or completely normal by coronary angiography.

Exclusion criteria

Exclusion criteria: 1. Patients allergic to iodine or iodine contrast agent; 2. Patients with severe cardiac insufficiency (stage IV), severe valvular heart disease, cardiomyopathy, hemodynamic instability, inability to lie on the back for more than 24 hours or using balloon counterpulsation; 3. Patients with severe liver and kidney dysfunction; 4. Patients with previous CABG and pacemaker implantation; 5. Patients with autoimmune diseases, hematological diseases, peripheral vascular diseases, malignant tumors and severe infectious diseases; 6. Patients with poor treatment compliance and those who do not cooperate with the examination.

Design outcomes

Primary

Measure	Time frame
absent in melanoma 2;	—

Countries

China

Contacts

Public ContactChengchun Tang

Zhongda Hospital Affiliated to Southeast University

tangchengchun@hotmail.com+86 13914705570

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026